Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2023
February 06 2024 - 4:05PM
Business Wire
Medifast (NYSE: MED), the health and wellness company known for
its habit-based and Coach-guided lifestyle solution,
OPTAVIA®, will announce financial results for the fourth
quarter and full year ended December 31, 2023 on Tuesday, February
20, 2024, after market close. The Company will host a conference
call to discuss the results with additional comments and details.
Company participants will be Dan Chard, Chairman and Chief
Executive Officer, and Jim Maloney, Chief Financial Officer.
The conference call is scheduled to begin at 4:30 p.m. ET on
February 20, 2024. The call will be broadcast live over the
Internet, hosted on the Investor Relations section of Medifast's
website at www.MedifastInc.com or directly at
https://viavid.webcasts.com/starthere.jsp?ei=1652383&tp_key=34080c5b97,
and will be archived online and available through May 20, 2024. To
join via telephone, listeners may dial (877) 451-6152.
A telephonic playback will be available from 8:30 p.m. ET,
February 20, 2024, through February 27, 2024. Participants can dial
(844) 512-2921 and enter access code 13743876 to hear the
playback.
About Medifast®:
Medifast (NYSE: MED) is the health and wellness company known
for its habit-based and coach-guided lifestyle solution
OPTAVIA®, which provides people with a simple, yet
comprehensive approach to help them achieve lasting optimal health
and wellbeing. OPTAVIA's lifestyle plans deliver clinically
proven health benefits as well as evidence-based tools, including
scientifically developed products and a framework for habit
creation reinforced by independent Coaches and Community support.
As a physician-founded company with a 40+ year history, Medifast is
a leader in the U.S. weight management industry. Through a
collaboration with the national virtual primary care provider
LifeMD, OPTAVIA customers have access to board-certified
affiliated clinicians and medications, such as GLP-1s, that support
treatment plans for obesity and other health conditions. The
company continues to innovate and build upon its scientific and
clinical heritage to fulfill its mission of offering the world
Lifelong Transformation, One Healthy Habit at a Time®. Medifast was
recognized in 2023 by Financial Times as one of The Americas'
Fastest Growing Companies and in 2022 as one of America's Best
Mid-Sized Companies by Forbes. For more information, visit
MedifastInc.com and OPTAVIA.com and follow @Medifast on
X.
MED-F
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240206961509/en/
Investor: Medifast, Inc. Steven Zenker
InvestorRelations@medifastinc.com 443-379-5256
Medifast (NYSE:MED)
Historical Stock Chart
From Oct 2024 to Nov 2024
Medifast (NYSE:MED)
Historical Stock Chart
From Nov 2023 to Nov 2024